Literature DB >> 17916804

MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1.

Yvonne M-S Tay1, Wai-Leong Tam, Yen-Sin Ang, Philip M Gaughwin, Henry Yang, Weijia Wang, Rubing Liu, Joshy George, Huck-Hui Ng, Ranjan J Perera, Thomas Lufkin, Isidore Rigoutsos, Andrew M Thomson, Bing Lim.   

Abstract

Hundreds of microRNAs (miRNAs) are expressed in mammalian cells, where they aid in modulating gene expression by mediating mRNA transcript cleavage and/or regulation of translation rate. Functional studies to date have demonstrated that several of these miRNAs are important during development. However, the role of miRNAs in the regulation of stem cell growth and differentiation is not well understood. We show herein that microRNA (miR)-134 levels are maximally elevated at day 4 after retinoic acid-induced differentiation or day 2 after N2B27-induced differentiation of mouse embryonic stem cells (mESCs), but this change is not observed during embryoid body differentiation. The elevation of miR-134 levels alone in mESCs enhances differentiation toward ectodermal lineages, an effect that is blocked by a miR-134 antagonist. The promotion of mESC differentiation by miR-134 is due, in part, to its direct translational attenuation of Nanog and LRH1, both of which are known positive regulators of Oct4/POU5F1 and mESC growth. Together, the data demonstrate that miR-134 alone can enhance the differentiation of mESCs to ectodermal lineages and establish a functional role for miR-134 in modulating mESC differentiation through its potential to target and regulate multiple mRNAs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916804     DOI: 10.1634/stemcells.2007-0295

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  106 in total

Review 1.  From microRNAs to targets: pathway discovery in cell fate transitions.

Authors:  Deepa Subramanyam; Robert Blelloch
Journal:  Curr Opin Genet Dev       Date:  2011-06-01       Impact factor: 5.578

2.  5-Aminoimidazole-4-carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiation.

Authors:  Hee-Don Chae; Man-Ryul Lee; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

Review 3.  Promoter-associated RNAs and promoter-targeted RNAs.

Authors:  Bing-Xue Yan; Jin-Xia Ma
Journal:  Cell Mol Life Sci       Date:  2012-03-14       Impact factor: 9.261

Review 4.  Genome-wide approaches in the study of microRNA biology.

Authors:  Melissa L Wilbert; Gene W Yeo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

Review 5.  Desperately seeking microRNA targets.

Authors:  Marshall Thomas; Judy Lieberman; Ashish Lal
Journal:  Nat Struct Mol Biol       Date:  2010-10       Impact factor: 15.369

6.  Retinoic acid and microRNA.

Authors:  Lijun Wang; Atharva Piyush Rohatgi; Yu-Jui Yvonne Wan
Journal:  Methods Enzymol       Date:  2020-03-28       Impact factor: 1.600

7.  CtBP-interacting BTB zinc finger protein (CIBZ) promotes proliferation and G1/S transition in embryonic stem cells via Nanog.

Authors:  Tomonori Nishii; Yu Oikawa; Yasumasa Ishida; Masashi Kawaichi; Eishou Matsuda
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 8.  Concise review: MicroRNA expression in multipotent mesenchymal stromal cells.

Authors:  Uma Lakshmipathy; Ronald P Hart
Journal:  Stem Cells       Date:  2007-11-08       Impact factor: 6.277

9.  Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic.

Authors:  Ntube N O Ngalame; Erik J Tokar; Rachel J Person; Yuanyuan Xu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2014-01-15       Impact factor: 4.849

10.  MicroRNA-125b is a novel negative regulator of p53.

Authors:  Minh T N Le; Cathleen Teh; Ng Shyh-Chang; Huangming Xie; Beiyan Zhou; Vladimir Korzh; Harvey F Lodish; Bing Lim
Journal:  Genes Dev       Date:  2009-03-17       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.